Healthcare Sales & Marketing Network News: end-stage renal disease

Searching News Database: end-stage renal disease

HSMN NewsFeed - 19 Dec 2025
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Jun 2024
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
Devices Venture Capital

HSMN NewsFeed - 24 Jun 2024
Harmony Biosciences Receives U.S. Food And Drug Administration Approval For Wakix(R) (Pitolisant) In Pediatric Patients With Narcolepsy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 23 Jun 2023
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jan 2023
Cadrenal Therapeutics (Nasdaq: CVKD) Granted FDA Fast Track Designation for Tecarfarin for Prevention of Systemic Thromboembolism of Cardiac Origin in Patients with End-Stage Renal Disease and Atrial Fibrillation
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Feb 2022
Artio Medical Welcomes New R&D Leaders and Accelerates Development of Amplifi(TM) Vein Dilation System
Devices Personnel

HSMN NewsFeed - 17 Nov 2021
NURTEC(R) ODT Approved In Kuwait For Acute Treatment Of Migraine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 3 Aug 2021
Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
Biopharmaceuticals

HSMN NewsFeed - 29 Jul 2021
Artio Medical Successfully Completes Enrollment of First-in-Human Trial Investigating the Amplifi(TM) Vein Dilation System
Devices

HSMN NewsFeed - 6 May 2021
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
Devices Endocrinology Acquisitions

HSMN NewsFeed - 8 Apr 2021
Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients
Biopharmaceuticals

HSMN NewsFeed - 6 Apr 2021
Mineralys Therapeutics Closes $40 Million Series A Funding
Biopharmaceuticals Cardiology Venture Capital Personnel

HSMN NewsFeed - 30 Oct 2020
Minimally Invasive Ellipsys System Creates Fused, Permanent Vascular Access for Dialysis
Devices

HSMN NewsFeed - 14 Oct 2020
Harmony Biosciences Receives FDA Approval For Expanded Use Of WAKIX(R) (pitolisant) For The Treatment Of Cataplexy In Adult Patients With Narcolepsy
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Sep 2020
Medtronic to Acquire Avenu Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 5 May 2020
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Biopharmaceuticals

HSMN NewsFeed - 17 May 2019
U.S. FDA Approves GATTEX(R) (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 10 Dec 2018
Rockwell Medical, Inc. Appoints New Vice President, Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Dec 2018
Variant Pharmaceuticals Secures $10 Million in Financing from Korean Company, Incon Co., Ltd.
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 12 Oct 2018
Rockwell Medical Provides Update on IV Triferic
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Oct 2018
Rockwell Medical Appoints VP, Strategic Accounts
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2018
Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 8 Aug 2018
Rockwell Medical Appoints New Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jul 2018
Ortho Clinical Diagnostics Launches New MicroTip Partnership Assays for Diabetes, Cardiac and Renal Testing, In Collaboration with Diazyme Laboratories, Inc.
Diagnostics Product Launch

HSMN NewsFeed - 9 Jul 2018
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
Devices Mergers & Acquisitions

HSMN NewsFeed - 29 May 2018
TrioxBio Announces Fast Track Designation Granted by U.S. FDA to Raviten(R) for the Treatment of Intradialytic Hypotension
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Apr 2018
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO(R) (fosnetupitant/ palonosetron) in the United States
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 19 Mar 2018
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada
Biopharmaceuticals Gastroenterology Licensing

HSMN NewsFeed - 12 Feb 2018
Ardelyx Announces Departure of Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jan 2018
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
Biopharmaceuticals Endocrinology Product Launch

HSMN NewsFeed - 11 Dec 2017
Ardelyx Announces License Agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited for Tenapanor in China
Biopharmaceuticals Gastroenterology Licensing

HSMN NewsFeed - 21 Nov 2017
Ardelyx Announces Updated Development Path for its Cardiorenal Pipeline
Biopharmaceuticals

HSMN NewsFeed - 28 Aug 2017
NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage(R) System One(TM)
Devices FDA

HSMN NewsFeed - 24 Aug 2017
Thomas Eklund New Chairman of Pharmalink
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Aug 2017
VentureMed Group Raises $15 Million Series B Equity Financing
Devices Interventional Venture Capital

HSMN NewsFeed - 15 Aug 2017
Pharmalink Strengthens Its Management Team. Appoints New Chief Financial Officer and Head of Communications
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 May 2017
Ardelyx Reports Successful Phase 3 T3MPO-1 Trial of Tenapanor in Patients with IBS-C
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 28 Feb 2017
RenalGuard(R) Shown to Significantly Protect High-Risk Patients Undergoing Coronary Interventional Procedures from Acute Kidney Injury
Devices Interventional

HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Feb 2017
NxStage Announces Appointment of Chief Medical Officer
Devices Personnel

HSMN NewsFeed - 29 Nov 2016
OxThera Raises EUR 32 Million to Complete Development of Oxabact(R) for Treatment of Primary Hyperoxaluria
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Nov 2016
Conditional Approval from the European Commission to Treat Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 24 Oct 2016
Baxter Launches HDx Therapy Enabled by THERANOVA to Provide High Performance Hemodialysis Treatments
Devices Product Launch

HSMN NewsFeed - 24 Oct 2016
Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 15 Jul 2016
Ardelyx to Raise $110 Million in a Private Placement
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Jun 2016
GORE(R) VIABAHN(R) Endoprosthesis Found to Provide Superior Patency and Reduced Interventions Versus Balloon Angioplasty Alone for Challenging AV Access Cases
Devices Interventional

HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Mar 2016
Bluegrass Vascular Technologies Announces First Clinical Use of the Surfacer(R) Inside-Out(R) Access Catheter System in Europe
Devices

HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Feb 2016
TVA Medical Receives Additional Reimbursement in Germany for the everlinQ(TM) endoAVF System
Devices Interventional Reimbursement

HSMN NewsFeed - 9 Dec 2015
Allena Pharmaceuticals Raises $53 Million in Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Oct 2015
Baxter Announces U.S. FDA Clearance for AMIA Automated Peritoneal Dialysis System with SHARESOURCE Connectivity Platform
Devices FDA

HSMN NewsFeed - 9 Sep 2015
Rockwell Medical Announces the U.S. Commercial Launch of Triferic(TM)
Biopharmaceuticals Product Launch

HSMN NewsFeed - 12 Mar 2015
CryoLife Provides Update on PerClot Litigation
Devices Surgery Litigation

HSMN NewsFeed - 10 Jul 2014
CryoLife Appoints Pat Mackin as President and Chief Executive Officer
Devices Surgery Personnel

HSMN NewsFeed - 29 May 2014
Flow Forward Announces Spinout from Novita, to Focus on Development of Lead Product, the AFE System(TM)
Devices

HSMN NewsFeed - 29 Apr 2014
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
Devices FDA

HSMN NewsFeed - 9 Apr 2014
Aethlon Medical (AEMD) Note: U.S. Clinical Progression
Devices

HSMN NewsFeed - 27 Mar 2014
CryoLife Acquires Distribution Rights and Purchase Option for ProCol(R) Vascular Bioprosthesis for Hemodialysis Access
Devices Distribution

HSMN NewsFeed - 27 Mar 2014
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
Biopharmaceuticals Devices Personnel

HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics

HSMN NewsFeed - 3 Mar 2014
U.S. FDA Approves Bydureon(R) Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Drug Delivery Endocrinology FDA

HSMN NewsFeed - 27 Dec 2013
European Medicines Agency (EMA) Accepts Otsuka's Marketing Authorisation Application (MAA) for Tolvaptan, an Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 29 Oct 2013
Pharmalink Receives US Orphan Drug Designation for Busulipo(TM), its Novel Oncology Product for Bone Marrow Transplantation
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 21 Oct 2013
Cubist Announces FDA Approval for Expanded Use of ENTEREG(R)
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 10 Jul 2013
CryoLife Receives FDA Premarket Approval (PMA) for New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System
Devices Cardiology FDA

HSMN NewsFeed - 9 Jul 2013
CryoLife Enhances International Presence with Appointment of Andres Sarmiento as Latin America Sales Manager
Devices Surgery Cardiology Personnel

HSMN NewsFeed - 19 Jun 2013
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza(R) (saxagliptin)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 18 Jun 2013
Rockwell Medical Receives $20 Million in New Financing
Biopharmaceuticals

HSMN NewsFeed - 10 Jun 2013
TVA Medical Raises $9.5 Million to Advance Minimally Invasive Therapy for End-Stage Renal Disease
Devices Venture Capital

HSMN NewsFeed - 30 Apr 2013
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
Devices FDA

HSMN NewsFeed - 29 Apr 2013
Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 4 Apr 2013
CryoLife Receives FDA Clearance For Next Generation HeRO Device
Devices FDA

HSMN NewsFeed - 13 Mar 2013
Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Feb 2013
NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients
Devices Regulatory

HSMN NewsFeed - 21 Feb 2013
NxStage Announces CE Mark Approval for New High Flow Capabilities with System One
Devices Regulatory

HSMN NewsFeed - 15 Jan 2013
Rex Medical Cleaner15 Rotational Thrombectomy System Receives 510(k) Clearance
Devices Interventional Distribution FDA

HSMN NewsFeed - 6 Jan 2013
AWAK Technologies Enters into an Exclusive Agreement with Baxter International for the Development of Wearable Dialysis Technology
Devices

HSMN NewsFeed - 5 Dec 2012
Sorbent Therapeutics Appoints Jason Levin Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2012
FDA Grants Diazyme Clearance to Market a New Biomarker for Early Detection of Kidney Disease, on the SMART Point of Care System
Diagnostics FDA

HSMN NewsFeed - 7 Jun 2012
OxThera Resumes Clinical Development of Hyperoxaluria Therapy
Biopharmaceuticals

HSMN NewsFeed - 15 May 2012
CryoLife to Acquire Hemosphere
Devices Mergers & Acquisitions

HSMN NewsFeed - 23 Apr 2012
Nephros Appoints John C. Houghton as President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 25 Jan 2012
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 15 Sep 2011
KAI Pharmaceuticals Signs Agreement for Development and Commercialization of KAI-4169 in Japan with Ono Pharmaceutical
Biopharmaceuticals

HSMN NewsFeed - 6 Sep 2011
Hemosphere Receives CE Mark Approval for the HeRO(R) Graft
Devices Regulatory

HSMN NewsFeed - 1 Jun 2011
GORE(R) Hybrid Vascular Graft Commercially Available in the United States
Devices

HSMN NewsFeed - 4 May 2011
NxStage(R) Advances Global Growth Strategy with System One Regulatory Approval and Distribution Agreement in Australia and New Zealand
Devices Distribution

HSMN NewsFeed - 14 Feb 2011
AlloCure Appoints Kevin J. Heyeck as Chief Business Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 7 Feb 2011
FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include Data Supporting the Recommended Adult Dose of REYATAZ/ritonavir 300/100 mg for HIV-1 Infected Pregnant Women
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 22 Nov 2010
New Data on H.P. Acthar(R) Gel in the Treatment of Nephrotic Syndrome Presented at the American Society of Nephrology 43rd Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 22 Nov 2010
Interim Results From Independent Study of H.P. Acthar(R) Gel in Patients With Advanced Diabetic Nephropathy Presented at American Society of Nephrology 43rd Annual Meeting
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 16 Nov 2010
Argon Medical Devices Announces Exclusive License and Distribution Agreement for 'UltraStream' Chronic Hemodialysis Catheter
Devices Distribution

HSMN NewsFeed - 21 Jul 2010
Keryx Biopharmaceuticals, Inc. Announces Appointment of Joseph Feczko, M.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jun 2010
Hemosphere, Inc., Names Patrick Wethington New CEO
Devices Personnel

HSMN NewsFeed - 5 Apr 2010
Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Refractory Advanced Colorectal Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 31 Mar 2010
Abbott Submits Test to Aid in Identifying Patients at Risk of Developing Kidney Injury
Diagnostics FDA

HSMN NewsFeed - 11 Mar 2010
Rex Medical Cleaner Rotational Thrombectomy System Receives 510(k) Clearance
Devices Interventional FDA

HSMN NewsFeed - 9 Mar 2010
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)
Biopharmaceuticals Cardiology Endocrinology

HSMN NewsFeed - 8 Mar 2010
NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome
Devices

HSMN NewsFeed - 1 Feb 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Jan 2010
Santé Ventures Invests $2.6MM in TVA Medical
Devices Venture Capital

HSMN NewsFeed - 21 Dec 2009
Gore Expands Line of GORE PROPATEN(R) Vascular Grafts
Devices Interventional

HSMN NewsFeed - 2 Dec 2009
Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 16 Sep 2009
Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 16 Sep 2009
Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 4 Aug 2009
Keryx Biopharmaceuticals Settles License Dispute With Alfa Wassermann
Biopharmaceuticals Licensing Litigation

HSMN NewsFeed - 2 Jul 2009
Nephros Receives 510k Approval for Dual Stage Ultrafilters
Devices FDA

HSMN NewsFeed - 20 May 2009
Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2009
Aethlon Medical Discloses New HIV/AIDS Treatment Data
Devices HIV/AIDS

HSMN NewsFeed - 5 May 2009
Pervasis Therapeutics Granted Orphan Drug Designation for Vascugel
Biopharmaceuticals Regenerative Medicine FDA

HSMN NewsFeed - 23 Apr 2009
Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Apr 2009
New Keppra XR(TM) Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Mar 2009
Aethlon Medical Announces Significant Viral Load Reduction in Landmark Medical Device Study to Treat HIV/AIDS
Devices HIV/AIDS

HSMN NewsFeed - 11 Mar 2009
Shire Announces Launch of FOSRENOL(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 9 Mar 2009
NxStage Reports Sustained Reduction in Clinical Depressive Symptoms for Daily Home Hemodialysis Patients After One Year
Devices

HSMN NewsFeed - 2 Mar 2009
Rockwell Medical Technologies, Inc. Appoints Richard Yocum, M.D. as VP of Drug Development and Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Feb 2009
Nephros Provides Update on 510k Applications
Devices FDA

HSMN NewsFeed - 3 Nov 2008
NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
Devices

HSMN NewsFeed - 21 Oct 2008
Pervasis Therapeutics Appoints Life Sciences Industry Executive Frederic Chereau as Company's President and Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 17 Sep 2008
Nephros Appoints James S. Scibetta as Chairman of Board of Directors
Devices Personnel

HSMN NewsFeed - 17 Sep 2008
Nephros Appoints Ernest A. Elgin III as President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 5 Aug 2008
Pervasis Therapeutics Appoints Frank Litvack, M.D., Former CEO of Conor Medsystems, to its Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 22 Jul 2008
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 15 May 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Biopharmaceuticals

HSMN NewsFeed - 21 Apr 2008
Nephros Strengthens Commercialization Team with Addition of Marketing Executive
Devices Personnel

HSMN NewsFeed - 7 Apr 2008
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
Biopharmaceuticals

HSMN NewsFeed - 31 Mar 2008
A Peritoneal-Based Wearable Artificial Kidney for Continuous Dialysis of Patients with End-Stage Renal Disease
Devices Licensing

HSMN NewsFeed - 24 Mar 2008
ConforMIS, Inc. Appoints Medical Device Veteran to Chief Operating Officer
Devices Personnel

HSMN NewsFeed - 13 Mar 2008
Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
Biopharmaceuticals

HSMN NewsFeed - 10 Mar 2008
Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 7 Mar 2008
Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 15 Feb 2008
Keryx Biopharmaceuticals Announces Additions to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2008
Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 25 Jan 2008
Ash Access Technology and Commercial Partner AngioDynamics Highlight Results From Preliminary Study of Centros(TM)
Devices

HSMN NewsFeed - 24 Jan 2008
Ash Access Technology, Inc. Completes Patient Enrollment in AZEPTIC Trial for Zuragen(R)
Biopharmaceuticals Devices

HSMN NewsFeed - 15 Jan 2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing
Regenerative Medicine Venture Capital

HSMN NewsFeed - 2 Jan 2008
Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals FDA Endocrinology Drug Delivery

HSMN NewsFeed - 14 Dec 2007
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Dec 2007
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
Biopharmaceuticals

HSMN NewsFeed - 20 Nov 2007
Nephros Receives Approval to Market OLpur(TM) MD Hemodiafilter Series in Canada
Devices Regulatory

HSMN NewsFeed - 20 Nov 2007
Nephros Appoints James S. Scibetta to Board of Directors
Devices Personnel

HSMN NewsFeed - 19 Nov 2007
Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve BP Goals
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 7 Nov 2007
Fresenius Medical Care Announces: Continued Positive Data from CARE-2 Database
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2007
Aethlon Medical Initiates Human Clinical Studies
Devices

HSMN NewsFeed - 29 Oct 2007
Depomed and King Pharmaceuticals Terminate Promotion Agreement for GLUMETZA(TM)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 17 Oct 2007
FDA Approves Supplemental New Drug Applications for JANUVIA(TM) (sitagliptin)
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 15 Oct 2007
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Oct 2007
Optherion, Inc. Completes $37 Million Start Up Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 1 Oct 2007
NxStage Medical Completes Acquisition of Medisystems
Devices Mergers & Acquisitions

HSMN NewsFeed - 25 Sep 2007
Nephros Raises $12.7 Million in New Financing
Devices Venture Capital

HSMN NewsFeed - 18 Sep 2007
One-Year Data Showed Investigational Use of Initial Combination Therapy with JANUVIA(TM) (sitagliptin) and Metformin Significantly Improved Blood Sugar Control in Patients with Type 2 Diabetes Compared to Metformin Alone
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 29 Aug 2007
NxStage Medical Provides Update on Medisystems Acquisition
Devices Mergers & Acquisitions Personnel

HSMN NewsFeed - 6 Aug 2007
Baxter Announces Collaboration for Development of Next-Generation Home Hemodialysis Machine
Devices

HSMN NewsFeed - 17 Jul 2007
Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Jun 2007
Aethlon Medical Announces Approval of Clinical Study
Devices

HSMN NewsFeed - 7 Jun 2007
Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA(TM)) Treatment for Patients with Amyloid A (AA) Amyloidosis
Biopharmaceuticals

HSMN NewsFeed - 29 May 2007
Angiotech initiates European trial examining the Vascular Wrap(TM) paclitaxel-eluting mesh for Dialysis Patients with End-Stage Renal Disease
Devices

HSMN NewsFeed - 29 May 2007
FDA Approves XYZAL(R) (Levocetirizine Dihydrochloride) Tablets for the Relief of Seasonal and Year Round Allergies, and Chronic Hives
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Apr 2007
Affymax(R) Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide(TM) for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease
Biopharmacetuicals

HSMN NewsFeed - 12 Apr 2007
Data Analyses Outline Efficacy and Safety of MIRCERA(TM) for the Treatment of Renal Anemia Associated With Chronic Kidney Disease
Biopharmaceuticals

HSMN NewsFeed - 11 Apr 2007
Neurochem's eprodisate (KIACTA(TM)) PDUFA date extended three months by FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Apr 2007
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 Mar 2007
Angiotech Initiates U.S. Pivotal Trial for the Vascular Wrap(TM) Paclitaxel-Eluting Mesh
Devices Interventional

HSMN NewsFeed - 19 Mar 2007
Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel(TM)
Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 12 Mar 2007
Cytochroma appoints co-founder Dr. P. Martin Petkovich as full-time Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2007
NxStage(R) Medical and DaVita Announce Agreement for Home Hemodialysis Using the NxStage System One(TM)
Devices

HSMN NewsFeed - 1 Feb 2007
Fresenius Medical Care and Amgen Enter New Commercial Collaboration in Europe
Biopharmaceuticals

HSMN NewsFeed - 29 Jan 2007
Nephros Receives Conditional Approval from the FDA of Investigational Device Exemption Application
Devices FDA

HSMN NewsFeed - 4 Jan 2007
AVEO Acquires Clinical Stage Anti-Cancer Compound From Kirin
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 1 Dec 2006
Merck Announces JANUMET(TM), the Trademark for its Investigational Combination Therapy of Sitagliptin Phosphate and Metformin for Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 27 Nov 2006
NxStage Medical, Inc. Appoints Robert S. Brown as Chief Financial Officer
Devices Personnel

HSMN NewsFeed - 20 Nov 2006
New Analyses Demonstrate Positive Effect on Bone With Fosrenol(R) Treatment Compared With Standard Therapy
Biopharmaceuticals

HSMN NewsFeed - 15 Nov 2006
Fresenius Medical Care Completes the Acquisition of the Phosphate Binder Business From Nabi Biopharmaceuticals
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 9 Nov 2006
Spire Introduces New Clot-Resistant Dialysis Catheter at ASN Renal Week 2006 Conference; Spire Biomedical Offers FDA-Approved Decathlon Gold(TM) Coated Catheter
Devices

HSMN NewsFeed - 23 Oct 2006
Multi-Center Study Concludes Nephros Mid-Dilution Hemodiafiltration Therapy Achieves Higher Clearance of Low Molecular Weight Proteins
Devices

HSMN NewsFeed - 19 Oct 2006
Fresenius Medical Care Announces New Sourcing and Supply Agreement with Amgen
Biopharmaceuticals

HSMN NewsFeed - 17 Oct 2006
FDA Approves Once-Daily JANUVIA(TM), the First and Only DPP-4 Inhibitor Available in the United States for Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology

HSMN NewsFeed - 12 Oct 2006
Fresenius Medical Care to Acquire Phosphate Binder Business from Nabi Biopharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Oct 2006
Nephros Announces Positive Results of Clinical Study for Olpur MD190 Mid-Dilution Hemodiafiltration Filter
Devices

HSMN NewsFeed - 4 Oct 2006
Kyowa Hakko Grants Keryx Biopharmaceuticals Exclusive Rights to UCN-01, a Novel, Anticancer Agent in Phase II Clinical Development
Biopharmaceuticals Licensing

HSMN NewsFeed - 27 Sep 2006
Pervasis Therapeutics' Vascugel(TM) Initiates U.S. Clinical Trials Following Successful FDA IND Review
Regenerative Medicine FDA

HSMN NewsFeed - 19 Sep 2006
PhytoMedical Announces Appointment of Senior Pharmaceutical Executives to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jul 2006
Nabi Biopharmaceuticals Releases New Data which Demonstrate Superior Serum Phosphorus Control with PhosLo(R) (calcium acetate) over Sevelamer
Biopharmaceuticals

HSMN NewsFeed - 28 Jun 2006
King Pharmaceuticals and Depomed Announce Agreement to Co-Promote Glumetza(TM)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 22 Jun 2006
La Jolla Pharmaceutical Company Files Marketing Authorization Application for European Regulatory Approval of Riquent
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 May 2006
NxStage Announces Executive Transition
Devices Personnel

HSMN NewsFeed - 10 May 2006
NephroGenex Licenses Pyridorin(TM) for Diabetic Nephropathy and Acute Renal Failure
Biopharmaceuticals Acquisitions Licensing

Return to NewsFeed

Additional items found! 95

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 95 additional stories matching:
end-stage renal disease
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.